Article
Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus
1 Apr 2021
Abstract excerpt
Accumulating evidence has suggested the importance of gut microbiota in the development of type 2 diabetes mellitus (T2DM). In the present study, 40 patients with T2DM were treated with liraglutide for 4 months. Feces samples and clinical characteristics were collected from these 40 T2DM patients before and after the liraglutide treatment. The diversity and composition of gut microbiota in the two groups were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
